Key Insights

Highlights

Treatment Research

2 treatments under study, led by Metformina Teva 850 Mg Compresse Rivestite Con Film

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Active Not Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
SYF0ac4abb7df83454a8fdc0536eb188a7ePhase 2Active Not Recruiting

Safety of Lanreotide 120 mg ATG in combination with Metformin in patients with progressive advanced Well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: the MetNET-2 trial

Showing all 1 trials

Research Network

Common Treatments

  • Metformina Teva 850 Mg Compresse Rivestite Con Film1
  • Ipstyl 120 Mg Soluzione Iniettabile In Siringa Preriempita1

Active Sponsors

  • Fondazione IRCCS Istituto Nazionale Dei Tumori1

Activity Timeline